3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
10
Uterine Cervical Neoplasms
9
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Urinary Bladder Neoplasms
5
Stomach Neoplasms
5
Small Cell Lung Carcinoma
4
Mesothelioma, Malignant
4
Medulloblastoma
4
Urethral Neoplasms
3
Oropharyngeal Neoplasms
3
Neuroblastoma
3
Head and Neck Neoplasms
3
Ganglioneuroblastoma
3
Cholangiocarcinoma
3
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Ureteral Neoplasms
2
Tongue Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Brenner Tumor
2
Brain Neoplasms
2
Vomiting
1
Interventions
tislelizumab
4
talazoparib
4
pembrolizumab
4
Docetaxel
4
Nivolumab
3
PM 01183
2
MLN 8237
2
Itraconazole
2
Fluorouracil
2
Cisplatin
2
Carboplatin
2
zimberelimab
1
utomilumab
1
urelumab
1
ulixertinib
1
trifluridine tipiracil drug combination
1
sitravatinib
1
sapanisertib
1
pexidartinib
1
pevonedistat
1
peposertib
1
niraparib
1
mogamulizumab
1
lenvatinib
1
ixabepilone
1
eribulin
1
durvalumab
1
dalotuzumab
1
avelumab
1
ascrinvacumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Solid Tumors
×
Platinum
×
Clear all
No trials found.